Article summary
Carhart-Harris will provide scientific and strategic input, meet regularly with management and introduce researchers, clinicians and academic institutions. Filament develops and supplies PEX010, a standardised, GMP-manufactured botanical psilocybin drug candidate for clinical research and compassionate access programmes.
Continue to the original publication for the complete article.